Categories: News

New Single-Use Beta Bags from Central Research Laboratories Improve Cost and Efficiency in the Manufacturing of Critical Life Science Products

DOWNERS GROVE, Ill., May 18, 2022 /PRNewswire/ — Central Research Laboratories (CRL), part of Destaco and Dover (NYSE: DOV), and a global leader in the remote-handling industry, today announced the launch of its new Single-Use Beta Bag product line. Single-Use Beta Bags are indispensable components in ready-to-use, component-transfer and waste-handling applications during the manufacturing of Life Science products.

“Our goal is to create and provide safe, reliable, efficient and cost-effective transfer solutions for every application need within the Life Sciences segment, and our new Single-Use Bags do just that,” said Chris Gooding, VP and GM at CRL. “We are pleased to offer another solution that will help our clients maximize their productivity.”

The new 190-mm Single-Use Beta Bags are available in two materials, Tyvek and HDPE (Tyvek-free), and designed for use with DTPE-style alpha ports. They are gamma-sterilizable, a process in which gamma rays are passed through the bag to kill any bacteria that may be present. These features make them an ideal solution for introducing components like stoppers, vials and needles into production lines, or for managing samples and removing waste. Their versatility also makes them a good option for kitting. CRL has a ready inventory of the new Single-Use Beta Bags on hand, which allows them to be shipped anywhere in the world.

For more information on CRL and its extensive family of remote-handling solutions, please visit crlsolutions.com.

About CRL & Destaco
Headquartered in Red Wing, MN, USA, Central Research Laboratories (CRL) became a Destaco company in 2007. It possesses more than 70 years of innovation experience in the development of remote-handling systems, including Telemanipulators, Transfer Systems, Glove Ports and Waste Drum Transfer Systems. CRL’s industry-leading technology helps its customers safely and efficiently handle hazardous and sterile materials in nuclear and life science applications around the world.

Destaco, a Dover company, is a global leader in the design and manufacture of high-performance automation, workholding and remote-handling solutions. The company serves customers in a variety of end-markets, including the automotive, life science, consumer packaged goods, aerospace, industrial and nuclear sectors.

Destaco is based in Auburn Hills, Michigan, U.S.A. The company has more than 800 employees with 13 locations, in 9 countries, across the Americas, Europe and Asia. More information is available at destaco.com

About Dover:
Dover is a diversified global manufacturer and solutions provider with annual revenue of approximately $8 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 65 years, our team of over 25,000 employees takes an ownership mindset, collaborating with customers to redefine what’s possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under “DOV.” Additional information is available at dovercorporation.com.

Destaco Contact:
Kristen Fairbrother
(248) 836-6674
kfairbrother@destaco.com

Dover Media Contact:
Adrian Sakowicz, VP, Communications    
(630) 743-5039    
asakowicz@dovercorp.com     

Dover Investor Contact:
Jack Dickens, Senior Director, Investor Relations
(630) 743-2566
jdickens@dovercorp.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-single-use-beta-bags-from-central-research-laboratories-improve-cost-and-efficiency-in-the-manufacturing-of-critical-life-science-products-301550419.html

SOURCE Dover

Staff

Recent Posts

BioSonic Bloom: What Published Research Says About 528 Hz and 432 Hz Audio Frequency Programs

An In-Depth Analysis of Digital Sound Frequency Programs, Binaural Beats Research, and Key Considerations for…

4 hours ago

Best TRT Injection for 2026: Fridays Lists Prescription Testosterone in Injectable and Oral Formats as Men Compare Telehealth Hormone Options

Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research…

4 hours ago

How Does Ozempic Work For Weight Loss? Best Weight Loss Supplement Launch By PhenQ

Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details –…

4 hours ago

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand

Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before…

4 hours ago

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

1 day ago